16 May
Chronicity Ecosystem Innovation

The “Siguemed” project from the startup Infármate, the winning solution in Cinfa’s open innovation challenge at Ances Open Innovation

The final event of the 6th edition of the Ances Open Innovation 2023 Open Innovation Programme was held at La Nave on 11 May. It was a day for the finalist startups to get to know each other and share their solutions to the challenges proposed by the eight leading companies that took part in this latest edition.

The initiative, promoted by ANCES (National Association of European Business and Innovation Centres), seeks to connect large companies and startups to generate different synergies that facilitate their joint progress in meeting the technological and innovation challenges. 

The 78 solutions suggested to respond to the challenges were presented in this call, thereby opening up the competition for the final prize and creating the chance to establish future collaborations with the trailblazing companies.

Cinfa will be taking part in this edition, together with companies from the agri-food, biotechnology, e-commerce, renewable energy and industrial sectors, including HMY, INAEL Electrical Systems, Mundiplan, MEISA, RECALVI Mediterránea, Repsol and Soltec. 

Find out about our challenge and the winning project

In February, here at CinfaNext we launched our open innovation challenge as part of this initiative, seeking to uncover new projects that would increase knowledge, management and adherence to treatments for chronic diseases to improve the quality of life of patients suffering from them.

The solutions presented were extremely diverse, ranging from digital solutions to new, more efficient treatments, adhesion enhancement systems and devices and technologies that enable better patient monitoring. The startup Infármate, which seeks the proper use and correct functioning of the medicines taken by polymedicated patients, was the company chosen by Cinfa as the winner of this challenge. Its “Siguemed” solution is an intelligent personal therapeutic dosage system (PDS) containing a digital band in the blister pack that allows it to detect and monitor whether or not the patient has taken their medication. It therefore improves monitoring of medication intake in the case of polymedicated patients and, consequently, adherence to treatment.

We would also like to congratulate two other finalists for their solutions to our challenge. The first is Mindsaic, specialists in creating software services that can be integrated into any website, allowing users to hold conversations through voice and writing, thanks to artificial intelligence. And the second is ReHand, a solution focused on digitising patient rehabilitation through artificial intelligence applied to devices such as tablets and mobiles. 

Now is the time to carry on the dialogue with these innovative actors to build the health of the future.